Webinar: Addressing COVID-19 - Jane Reed and Kirsten McLaughlin
Jane Reed is Director of Life Sciences at Linguamatics, and in discussion with Kirsten McLaughlin, she described how Linguamatics is using its expertise in NLP to address the challenges of COVID-19, where access to the richness of information from unstructured text is essential. In the short term, NLP can help with finding and prioritizing drugs for repurposing; in the medium term getting information on the SARS-CoV-2 virus to enable vaccine development; and longer term thinking about patient care in a post-COVID world.
Jane highlighted three main Linguamatics initiatives to provide more rapid, effective access to COVID-19 related intelligence from unstructured text.
- The first are dashboards with access to global publications and data sources. These include new indexes, terminologies and queries relevant for COVID-19 and the SARS-CoV-2 virus, and they are available for all Linguamatics OnDemand cloud users.
- The second is the continued development of new terminologies, focused on coronavirus species and diseases, and adding a symptoms terminology. The third is the Evidence Hub for COVID-19, which is a cloud-based platform providing rapid, systematic insight generation from multiple text sources.